Two Sigma Investments
BMY icon

Two Sigma Investments’s Bristol-Myers Squibb BMY Stock Holding History

Two Sigma Investments’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.17M Buy
+35,700
New +$2.08M ﹤0.01% 2700
2022
Q1 		– Sell
-174,700
Closed -$10.9M – 2817
2021
Q4 		$10.9M Buy
174,700
+161,900
+1,265% +$9.5M 0.02% 739
2021
Q3 		$757K Sell
12,800
-68,200
-84% -$4.49M ﹤0.01% 2880
2021
Q2 		$5.41M Sell
81,000
-124,200
-61% -$8.1M 0.01% 1149
2021
Q1 		$13M Buy
205,200
+187,500
+1,059% +$11.7M 0.03% 600
2020
Q4 		$1.1M Sell
17,700
-71,900
-80% -$4.42M ﹤0.01% 1922
2020
Q3 		$5.4M Buy
+89,600
New +$5.39M 0.02% 764
2020
Q2 		– Sell
-271,500
Closed -$15.1M – 2962
2020
Q1 		$15.1M Buy
271,500
+206,200
+316% +$12.6M 0.12% 169
2019
Q4 		$4.19M Sell
65,300
-125,000
-66% -$7.16M 0.01% 1075
2019
Q3 		$9.65M Buy
190,300
+144,500
+316% +$6.79M 0.03% 559
2019
Q2 		$2.08M Buy
45,800
+26,900
+142% +$1.25M 0.01% 1423
2019
Q1 		$902K Buy
+18,900
New +$941K ﹤0.01% 1896
2018
Q4 		– Sell
-16,500
Closed -$1.02M – 2997
2018
Q3 		$1.02M Sell
16,500
-127,600
-89% -$7.57M ﹤0.01% 1964
2018
Q2 		$7.97M Buy
144,100
+78,700
+120% +$4.25M 0.02% 769
2018
Q1 		$4.14M Buy
+65,400
New +$4.21M 0.01% 1065
2017
Q2 		– Sell
-54,900
Closed -$2.98M – 2962
2017
Q1 		$2.98M Buy
54,900
+700
+1% +$38.4K 0.01% 1212
2016
Q4 		$3.17M Sell
54,200
-115,800
-68% -$6.33M 0.01% 1149
2016
Q3 		$9.17M Buy
170,000
+99,000
+139% +$6.36M 0.03% 580
2016
Q2 		$5.22M Buy
71,000
+26,200
+58% +$1.85M 0.02% 756
2016
Q1 		$2.86M Buy
44,800
+2,800
+7% +$177K 0.01% 968
2015
Q4 		$2.89M Buy
+42,000
New +$2.78M 0.01% 901

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments's BMY Position: Q1 2026 in Review

Two Sigma Investments increased its Bristol-Myers Squibb (BMY) stake by 147% in Q1 2026, buying an estimated $401M and bringing the position to 11,535,106 shares worth $700M. The position accounts for 0.56% of the portfolio, ranked #16.

Two Sigma Investments first reported a position in BMY in Q3 2013 and has held it in 45 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Two Sigma Investments held 11,535,106 shares of Bristol-Myers Squibb worth $700M as of Q1 2026.
  • Two Sigma Investments bought 6,873,064 Bristol-Myers Squibb shares in Q1 2026, an estimated $401M.
  • Bristol-Myers Squibb made up 0.56% of Two Sigma Investments's portfolio in Q1 2026, its #16 holding.
  • Two Sigma Investments first reported a position in Bristol-Myers Squibb in Q3 2013 and has held it in 45 quarters since.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.